NEW GENE OF PSORIATIC ERYTHRODERMA AND PROBABLE PATHOGENESIS OF THE DISEASE


  • A.A. Sidikov St.Petersburg State Pediatric Medical University, Russian Federation
  • D.V. Zaslavsky St.Petersburg State Pediatric Medical University, Russian Federation
  • A.K. Emelyanov I.P. Pavlov First St. Petersburg State Medical University, Russian Federation
  • I. N. Chuprov I.I. Mechnikov North-Western State Medical University, Russian Federation
  • M.O. Guliev H.M.Berbekov Kabardino-Balkarian state university, Kabardino-Balkar Republic
  • E.V. Grekova V.A. Rakhmanov Department of Skin and Veneral Diseases, I.M. Sechenov First Moscow State Medical University, Russian Federation
  • R.A. Nasyrov St.Petersburg State Pediatric Medical University, Russian Federation
Keywords: connexin 26, GJB2 gene mutation, M34T, V37I, R127H, calcium, erythroderma, psoriatic erythroderma, disturbance of skin barrier

Abstract

NEW GENE OF PSORIATIC ERYTHRODERMA AND PROBABLE PATHOGENESIS OF THE DISEASE

References

1. Elsholz F, Harteneck C, Muller W, Friedland K. Calcium--a central regulator of keratinocyte differentiation in health and disease. Eur J Dermatol. 2014;24(6):650-61.

2. Sanchez HA, Villone K, Srinivas M, Verselis VK. The D50N mutation and syndromic deafness: Altered Cx26 hemichannel properties caused by effects on the pore and intersubunit interactions. J Gen Physiol. 2013; 142: 3–22.

3. Sanchez HA, Slavi N, Srinivas M, Verselis VK. Syndromic deafness mutations at Asn 14 differentially alter the open stability of Cx26 hemichannels. J Gen Physiol. 2016; 148: 25–42.

4. Mese G, Sellitto C, Li L, Wang HZ, Valiunas V, Richard G,Brink PR, White TW. The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome. Mol Biol Cell. 2011; 22: 4776–4786.

5. Schutz M, Auth T, Gehrt A, Bosen F, Korber I, Strenzke N, Moser T, Willecke K. 2011. The connexin26 S17F mouse mutant represents a model for the human hereditary keratitis- ichthyosis-deafness syndrome. Hum Mol Genet 20: 28–39.

6. Sanchez HA, Verselis VK. Aberrant Cx26 hemichannels and Keratitis-Ichthyosis-Deafness Syndrome: Insights into syndromic hearing loss. Front Cell Neurosci. 2014; 8: 354.

7. Lee JR, WhiteTW. Connexin-26 mutations in deafness and skin disease. Expert Rev Mol Med. 2009; 11: e35. doi: 10.1017/ S1462399409001276.

8. Bosen F, Celli A, Crumrine D, Vom Dorp K, Ebel P, Jastrow H, Dormann P, Winterhager E, Mauro T, Willecke K. Altered epidermal lipid processing and calcium distribution in the KID syndrome mouse model Cx26S17F. Federation of European Biochemical Societies. 2015; 589: 1904–1910.

9. Garcıa IE, Maripilla´n J, Jara O, Ceriani R, Palacios-Munoz A, Ramachandran J, Olivero P, Perez-Acle T, González C, Sáez JC, Contreras JE, Martínez AD. Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43. J Invest Dermatol 2015;135:1338 - 47.

10. Chan D.K., Chang KW. GJB2-associated hearing loss: Systematic review of worldwide prevalence, genotype, and auditory phenotype. Laryngoscope. 2014;124(2):E34-53.

11. Rita Teek, Katrin Kruustuk, Riina Zordania, Kairit Joost, Tiia Reimand, Tonu Mols , Eneli Oitmaa, Tiina Kahre , Neeme To˜nisson , Katrin O˜ unap. Prevalence of c.35delG and p.M34T mutations in the GJB2 gene in Estonia. International Journal of Pediatric Othorinolaryngology. 2010; 74 .P. 1007-1012.

12. Keita Tsukada, MD, Shin-ya Nishio, Mitsuru Hattori, and Shin-ichi Usami. Ethnic-Specific Spectrum of GJB2 and SLC26A4 Mutations: Their Origin and a Literature Review. Annals of Otology, Rhinology & Laryngology. 2015, Vol. 124(5S) 61S–76S.

13. Tiago D. Matos, Helena Simoes-Teixeira, Helena Caria, Helena Rosa, Assuncao O’Neill and Graca Fialho. The Controversial p.Arg127His Mutation in GJB2: Report on Three Portuguese Hearing Loss Family Cases. Genetic testing and molecular biomarkers. 2010; V. 14. N.1. P. 141-144.

14. Marlin S, Garabe´dian EN, Roger G, et al. Connexin 26 gene mutations in congenitally deaf children: pitfalls for genetic counseling. Arch Otolaryngol Head Neck Surg. 2001; 127:927–933.

15. Mese G, Londin E, Mui R, et al. Altered gating properties of functional Cx26 mutants associated with recessive nonsyndromic hearing loss. Hum Genet. 2004; 115:191–199.

16. Wu BL, Lindeman N, Lip V, et al. Effectiveness of sequencing connexin 26 (GJB2) in cases of familial or sporadic childhood deafness referred for molecular diagnostic testing. Genet Med. 2002; 4:279–288.

17. Pollak A, Sko´ rka A, Mueller-Malesin´ska M, et al. M34T and V37I mutations in GJB2 associated hearing impairment: evidence for pathogenicity and reduced penetrance. Am J Med Genet A. 2007;.143A:2534–2543.

18. Huculak C, Bruyere H, Nelson TN, et al. (2006) V37I connexin 26 allele in patients with sensorineural hearing loss: evidence of its pathogenicity. Am J Med Genet A 140A:2394–2400.

19. Guerci VI, Grasso DL, Morgutti M, et al. Connexin 26 gene: defining the role of the V153I mutation. Audiol Med. 2007; 5:200–206.

20. Bayazit YA, Cable BB, Cataloluk O, et al. GJB2 gene mutations causing familial hereditary deafness in Turkey. Int J Pediatr Otorhinolaryngol.2003; 67:1331–1335.

21. Bicego M, Beltramello M, Melchionda S, et al. Pathogenetic role of the deafness-related M34T mutation of Cx26. Hum Mol Genet . 2006; 15:2569–2587.

22. Kim J, Jung J, Lee MG, Choi JY and Lee KA. Non-syndromic hearing loss caused by the dominant cis mutation R75Q with the recessive mutation V37I of the GJB2 (Connexin 26) gene. Experimental & Molecular Medicine. 2015; 47, e169. doi:10.1038/emm.2015.32

23. Matos TD, Caria H, Simoes-Teixeira H, et al. A novel hearing loss related mutation occurring in the GJB2 basal promoter. J Med Genet. 2007; 44:721–725.

24. Thonnissen E, Rabionet R, Arbone`s ML, et al. Human connexin26 (GJB2) deafness mutations affect the function of gap junction channels at different levels of protein expression. Hum Genet 2002; 111:190–197.
Published
2018-11-15
How to Cite
Sidikov, A., Zaslavsky, D., Emelyanov, A., Chuprov, I. N., Guliev, M., Grekova, E., & Nasyrov, R. (2018). NEW GENE OF PSORIATIC ERYTHRODERMA AND PROBABLE PATHOGENESIS OF THE DISEASE. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 2(2), 31-33. https://doi.org/10.29256/v.02.02.2018.escbm24
Section
Selected abstracts